ACP Nimble Buyer, Inc. is recalling 58,176 units of Mometasone Furoate Cream (0.1%), a prescription topical medication used for skin conditions. The recall was issued because of a typographical error on the label regarding the National Drug Code (NDC), which could lead to errors in medication identification or pharmacy processing. This recall affects 45-gram tubes manufactured by G&W Laboratories and distributed nationwide across the United States.
The typographical error on the product label involves the NDC number, which is a critical identifier for prescription drugs. This error may cause confusion for pharmacists and healthcare providers when dispensing or recording the medication, though it does not impact the safety or efficacy of the cream itself.
Drug Recall Refund/Guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.